On Monday, May 27, 2024, two employees at Samsung Electronics’ Giheung microchip manufacturing plant, 25 miles south of Seoul were exposed to radiation.
On Wednesday the South Korean Nuclear Safety and Security Commission stated that the workers’ blood work was normal; however, they showed “abnormal symptoms” on their fingers due to the localized nature of the exposure, according to Al Arabiya News.
The employees also took a chromosome abnormality test.
The employees were hospitalized at the Korea Institute of Radiological and Medical Sciences, but according to an update from Yonhap News Agency, they will receive outpatient treatment moving forward.
South Korean authorities are launching an investigation into the incident. According to Bloomberg, a Samsung spokesperson said that the company is cooperating with authorities in the investigation, and providing the employees with support as they receive treatment and recover.
Samsung’s stock took a tumble throughout Wednesday, closing 3.09% down.
Also read
Overall, despite Samsung being a significant player in the microchip industry, its shares have shown uneven performance throughout the year.
Although the conglomerate saw its stock briefly rally, reaching almost unprecedented heights in April, the overall outlook is moderately negative.
As of markets’ close on Wednesday, the company’s shares are down 5.53% year-to-date.
